Sensorion provides update on Phase 2 study of SENS-401 (Arazasetron) to treat Sudden Sensorineural Hearing Loss (SSNHL) March 13, 2020https://finance.yahoo.com/news/sensorion-provides-sens-401-ssnhl-063000237.html Sensorion provides update on SENS-401 SSNHL Phase 2 AUDIBLE-S trial enrollment